Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

226 results about "Macrocyclic lactone" patented technology

Trichoderma asperellum TS7-1 capable of efficiently degrading macrolide antibiotics and application of trichoderma asperellum TS7-1

The invention discloses trichoderma asperellum TS7-1 capable of efficiently degrading macrolide antibiotics and application of the trichoderma asperellum TS7-1, and belongs to the technical field of microorganisms. The preservation number of the trichoderma asperellum TS7-1 is CGMCC (China General Microbiological Culture Collection Center) No. 41372. The Trichoderma asperellum TS7-1 (CGMCC No.41372) provided by the invention has high-efficiency degradation capability on various macrolide antibiotics (erythromycin, roxithromycin and azithromycin), the removal rates of the Trichoderma asperellum TS7-1, roxithromycin and azithromycin in 36h all reach 85% or above, and the Trichoderma asperellum TS7-1 has high-concentration antibiotic tolerance, degradation rate and degradation spectrum obviously superior to those of other strains in the prior art. The trichoderma asperellum TS7-1 is directly separated from a natural soil body which is not polluted by antibiotics, has no animal and plant pathogenicity hidden danger, has no microbial toxicity to degradation products of macrolide antibiotics, avoids secondary pollution, and has excellent environmental safety.
Owner:UNIV OF SCI & TECH OF CHINA

Bacteriostatic composition and application thereof in control of staphylococcus aureus pollution

The invention discloses a bacteriostatic composition which comprises a synergist and a bacteriostatic agent, the synergist is ethyl phenylacetate or a derivative thereof, and the bacteriostatic agent is selected from hydrogen peroxide, beta-lactam antibiotics, macrolide antibiotics and aminoglycoside antibiotics. The synergist disclosed by the invention is wide in synergistic effect spectrum range, and has a remarkable synergistic bacteriostatic effect when being combined with hydrogen peroxide, amoxicillin, ampicillin, benzylpenicillin potassium, erythromycin, azithromycin and amikacin; the antibacterial effect is weak when the compound is independently used, but the virulence of staphylococcus aureus can be remarkably reduced, the formation of hemolysin, staphylococcus flavin, enterotoxin and a biofilm can be inhibited, and meanwhile, the selective pressure on bacteria is favorably reduced due to the relatively low antibacterial activity, so that the occurrence of drug resistance is delayed; the method is suitable for various application scenes such as food processing industry.
Owner:SHANGHAI JIAOTONG UNIV

Mass spectrum ionization element for macrolide antibiotic detection and preparation method thereof

The present invention relates to the field of analytical chemistry, and discloses a mass spectrum ionization element for macrolide antibiotic detection and a preparation method thereof, the mass spectrum ionization element comprises: a conductive substrate made of stainless steel; the adsorption layer is attached to at least part of the surface of the substrate, the adsorption layer is formed by a boric acid functionalized covalent organic framework, and the boric acid functionalized covalent organic framework is of a polycyclic structure composed of repeated units shown in the formula I in the specification. The mass spectrum ionization element is uniform in coating, high in selectivity on macrolide enriched antibiotics in a complex matrix and high in enrichment capacity, an eluent of the mass spectrum ionization element can be used for detection based on a liquid chromatography method and can also serve as a mass spectrum ion source solid substrate, mass spectrum detection is conducted through electrospray ionization, the detection steps are simple, and the mass spectrum ionization element is suitable for mass spectrum detection. And the detected background noise is low.
Owner:CHINESE ACAD OF INSPECTION & QUARANTINE

Fe3O4-COOH-coated ZIF-8-pDA-coated MIPs composite material and preparation method and application thereof

The invention discloses a Fe3O4-COOH (at) ZIF-8-pDA (at) MIPs composite material as well as a preparation method and application thereof. The material comprises carboxyl functionalized magnetic MOFs (Fe3O4-COOH (at) ZIF-8) and a synthesized molecularly imprinted composite material (Fe3O4-COOH (at) ZIF-8-pDA (at) MIPs) loaded on the carboxyl functionalized magnetic MOFs (Fe3O4-COOH (at) ZIF-8). The application of the composite material is that the composite material is applied to pretreatment and enrichment of macrolide antibiotics in an environmental water sample by a magnetic solid phase extraction (MSPE) technology. According to the molecularly imprinted composite material disclosed by the invention, rapid, sensitive and strong-specificity extraction can be realized by using a small amount of adsorbent and sample in a short time, and the molecularly imprinted composite material is economical and applicable. According to the method, the adsorption extraction agent can be screened, designed, regulated and controlled according to the structure of the target analyte, a new thought is provided for analysis of other environmental pollutants, and the method is of great significance to environmental risk assessment, pollutant control and public health.
Owner:EAST CHINA NORMAL UNIV

Recombinant macrolide enzyme as well as preparation method and application thereof

According to the scheme, the invention provides the recombinant macrolide enzyme as well as the preparation method and the application thereof, the amino acid sequence of the recombinant macrolide enzyme is as shown in SEQ ID NO.1, and the recombinant macrolide enzyme is derived from an EreC esterase family of enterobacter hormaechei and is obtained through site-specific mutagenesis; the mutation sites are as follows: glutamic acid at the 44th site is mutated into asparagine, tyrosine at the 55th site is mutated into proline, proline at the 76th site is mutated into arginine, phenylalanine at the 153rd site is mutated into alanine, and serine at the 219th site is mutated into glutamic acid. The method is expected to remove macrolide antibiotic pollution, and has good economic benefits and practical values.
Owner:浙江泰林生命科学有限公司

Key intermediate for synthesizing grass moss compound and method for synthesizing grass moss compound

The invention discloses a key intermediate for synthesizing a bryochratoxin compound and a method for synthesizing the bryochratoxin compound, and belongs to the field of chemical synthesis.The synthesis method of the key intermediate comprises the steps that a compound shown in the formula (III) is dissolved in a reaction solvent, then Lewis acid is added for an intramolecular Prins cyclization reaction, and the compound shown in the formula (III) is obtained. Obtaining a compound as shown in a formula (IV); then carrying out iodination and carbonylation reactions of exocyclic double bonds of the B ring to convert the olefin into an olefine acid ester compound; after the key common intermediates are obtained, grass moss 1, 7 and 9 and grass moss 9-N3 analogues can be respectively synthesized, so that divergent synthesis of the grass moss analogues is realized; according to the invention, through an esterification reaction of C1 carboxyl and C25 hydroxyl, acetalation of C15 aldehyde group is carried out at the same time, and then through a closed-loop strategy of constructing a macrolide skeleton through gem-bisilicon-mediated intra-molecular stereoselective Prins cyclization, specific selective construction of the cis-Z type of the B ring in the carex 1 is realized.
Owner:SICHUAN UNIV

Molecular sieve 13X-based enhanced aerobic compost humification and pollution control synergistic treatment method

The invention provides a synergistic treatment method for intensifying aerobic compost humification and preventing and controlling pollution based on a molecular sieve 13X, and relates to the field of solid waste treatment. The method comprises the following steps: mixing livestock and poultry manure with composting auxiliary materials, adjusting the water content and the carbon nitrogen ratio, adding a molecular sieve 13X, and then carrying out conventional aerobic composting so as to strengthen humification, gas emission reduction and resistance gene removal in the composting process; the humic acid HA in the obtained compost rotten product is increased by 18.1% compared with that in a control group, and the humate-rich ratio is increased by 59.6%; the cumulative emissions of CO2, CH4, N2O, NH3, H2S, MeSH and Me2S are respectively reduced by 13.1%, 14.8%, 25.7%, 20.4%, 33.6%, 21.9% and 20.7% compared with the control group; the relative abundance of tetracycline resistance genes, aminoglycoside resistance genes, macrolide resistance genes and clindamycin resistance genes in a compost product is reduced by 72.7%, 92.6%, 87.1% and 86.2% respectively compared with a control group, and the relative abundance of a movable genetic element MGEs is reduced by 94.1% compared with the control group; according to the method, efficient recycling and harmlessness of the organic solid waste can be synchronously achieved, and gas emission in the composting process is reduced.
Owner:JIANGSU ACAD OF AGRI SCI

Zearalenone hydrolase ZHRnZ, coding gene and application of zearalenone hydrolase ZHRnZ

The invention belongs to the technical field of agricultural biology, and particularly relates to zearalenone hydrolase ZHRnZ as well as a coding gene, a preparation method and application thereof. The amino acid sequence of the zearalenone hydrolase ZHRnZ provided by the invention is as shown in SEQ ID NO.1, and the nucleotide sequence of the coding gene of the zearalenone hydrolase ZHRnZ is as shown in SEQ ID NO.2. The hydrolase provided by the invention has relatively strong degradation capability on zearalenone, derivatives of zearalenone and macrolide antibiotics, and is high in degradation speed. The method has a huge application prospect in the fields of degradation of feed, food, biomass energy, Chinese herbal medicine mycotoxin and antibiotics.
Owner:CHINA AGRI UNIV

Insect pest-controlling tool for animals

An insect pest-controlling tool for animals is provided.The present invention provides an insect pest-controlling tool for animals comprising: at least one or more active ingredients selected from the group consisting of pyrethroid compounds, phenylpyrazole compounds, and macrolide compounds; and at least one solvent selected from the group consisting of diethylene glycol monoethyl ether, benzyl alcohol, ethyl lactate, and triglyceride of medium chain fatty acids. The container body is composed of an olefinic resin layer, an alicyclic olefinic resin layer, an olefinic resin layer, and a polyethylene terephthalate layer or an ethylene-vinyl alcohol copolymer layer. The olefinic resin layer is in contact with the agent.
Owner:OSAKA PHARMA

A method for removing resistance genes and promoting humification in enhanced aerobic composting

The present invention provides a method for enhancing the removal of resistance genes and promoting humification in aerobic composting. The method comprises the following steps: mixing livestock and poultry manure with a composting auxiliary material, adjusting the moisture content to 55%-65%, and adding a MnFe2O4 additive to obtain a composting raw material; aerobically composting the material, turning the compost every 2-3 days during a temperature rise period and a high temperature period, and every 7 days during a temperature fall period and a mature period, with the aerobic composting time being 20-30 days. Compared with a conventional composting method, the relative abundances of sulfonamide, tetracycline, macrolide, and aminoglycoside resistance genes in the mature compost obtained by the method are reduced by 60%-73%, 50%-57%, 20%-80%, and 45%-66%, respectively, and the humic acid (HA) content is increased by about 15%. Meanwhile, the method achieves efficient harmlessness and resource utilization of organic solid waste, and has the potential for large-scale production.
Owner:JIANGSU ACAD OF AGRI SCI

Method for enhancing resistance gene removal and promoting humification in aerobic compost

A method for enhancing resistance gene removal and promoting humification in an aerobic compost, which method comprises mixing livestock and poultry manure with compost auxiliary materials, adjusting the water content, adding an MnFe2O4 additive, and then performing aerobic composting for 20-30 days. Compared with conventional composting methods, the mature compost product obtained by means of the method exhibits a 60%-73% reduction in the relative abundance of sulfonamide resistance genes, a 50%-57% reduction in tetracycline resistance genes, a 20%-80% reduction in macrolide resistance genes, and a 45%-66% reduction in aminoglycoside resistance genes, and shows approximately a 15% increase in humic acid HA. This method achieves both efficient harmless treatment and resource utilization of organic solid waste.
Owner:JIANGSU ACAD OF AGRI SCI

High-packaging-dose antibacterial slow-release biological patch

InactiveCN119564935AInhibition of colonizationstop breedingProsthesisSurgical operationMacrocyclic lactone
The invention relates to the field of new biological materials, in particular to a high-packaging-dose antibacterial slow-release biological patch obtained by packaging at least two antibiotics with an acellular matrix material. The acellular matrix material is derived from any two of small intestinal submucosa, peritoneum, dermis, bladder basement membrane and pericardium; the antibiotics comprise hydrophobic antibiotics and hydrophilic antibiotics, and the hydrophobic antibiotics are selected from one or more of Beta-lactam antibiotics, rifamycin and macrolide antibiotics; the hydrophilic antibiotics are tetracycline antibiotics. The coating-free drug-loaded sustained-release system based on a lamination process kills bacteria in a short period, prevents colonization and reproduction of bacteria in a wound / patch, realizes synergistic and continuous release of antibiotics along with a wound healing process, guides tissue regeneration and synchronously realizes degradation, is applied to a high-incidence infection period of a surgical operation, reduces adhesion, and has a good application prospect. The abdominal wall strength is enhanced, and the growth of wound granulation tissues is promoted.
Owner:EXCELLENCE MEDICAL TECH SUZHOU CO LTD +1

Method for degrading residual antibiotics in macrolide antibiotic fermentation waste

The invention discloses a method for degrading residual antibiotics in macrolide antibiotic fermentation waste. The method comprises the following steps: taking antibiotic mushroom dregs as a degradation raw material, stainless steel beads as a grinding medium, and taking an oxidizing agent and a pro-oxidizing agent as ball milling aids. The mixture is subjected to a grinding reaction in a ball milling tank, treatment of the mushroom dregs is completed, the content of antibiotics in the mushroom dregs obtained after ball milling is reduced to 99% or below, the antibiotic resistance of the antibiotics disappears, and the mushroom dregs can be further used for re-fermentation of erythromycin. The method has the advantages that the process route is short, the reagent dosage is small, the price is low, operation is easy, the whole process is carried out under the solid-phase condition, no solvent is needed, the degradation efficiency is good, and the method has good application and popularization prospects.
Owner:ZHEJIANG UNIV OF TECH

Method for determining residual quantity of 16 veterinary drugs in animal-derived food by combining QuEChERS with high performance liquid chromatography-tandem mass spectrometry

The invention relates to a method for determining the residual quantity of 16 veterinary drugs in animal-derived food by QuEChERS combined with high performance liquid chromatography-tandem mass spectrometry, which comprises the following steps: dispersing an animal-derived food sample in water, extracting with a formic acid acetonitrile solution and an extraction salt package, the extraction salt package being anhydrous sodium sulfate and sodium chloride, and obtaining an extracting solution; a QuEChERS purifying agent is adopted to purify the extracting solution, the QuEChERS purifying agent is PSA, C18 and anhydrous magnesium sulfate, and supernate is taken after centrifugation; sequentially carrying out concentration, redissolution, acetonitrile saturated normal hexane purification and filtration treatment on the supernate to obtain a to-be-detected solution; and detecting the residual quantity of 16 veterinary drugs in the to-be-detected liquid by using a high performance liquid chromatography-tandem mass spectrometry method. According to the method, QuEChERS is combined with high performance liquid chromatography-tandem mass spectrometry to measure the residual quantity of 16 common veterinary drugs such as sulfonamides, quinolones and macrolides, methodological investigation and tests confirm that the method is high in detection speed, high in sensitivity and good in reproducibility, and the method is a rapid and effective means for simultaneously measuring the residual quantity of various veterinary drugs.
Owner:FUJIAN INST OF MICROBIOLOGY

Quinolone derivative of macrolide as well as preparation method and application of quinolone derivative

The invention provides a compound as shown in a formula (I), and a stereoisomer, a tautomer, an isotope label, nitrogen oxide, a solvate, a polymorphic substance, a metabolite, ester, pharmaceutically acceptable salt or prodrug thereof, or a pharmaceutical composition thereof, which have better antibacterial and anti-inflammatory effects, can be used as an antibiotic, and can be used for preparing a pharmaceutical preparation for preventing and treating diseases. The compound can treat infection caused by pathogenic microorganisms resistant to erythromycin and telithromycin, and simultaneously acts on double targets of ribosome and topoisomerase.
Owner:BEIJING INST OF TECH

Polyketone macrolide compound and application thereof

The invention belongs to the technical field of microbial pharmacy, and discloses a polyketone macrolide compound generated by genetically engineered streptomyces as well as a preparation method and application thereof. The polyketone macrolide compound disclosed by the invention is a cinnamyl streptomycin derivative, has cell proliferation inhibition activity better than that of a natural product Cinnamomycin A-D, can exert anti-tumor activity by inhibiting activity of human exonucleotide pyrophosphatase / phosphodiesterase 1 (ENPP1) and activating an inherent immune pathway, can be prepared into a medicine or a medicinal composition, and can be used for preparing medicines or medicinal compositions. The compound is used for treating tumors and related diseases.
Owner:CHINA PHARM UNIV

An antitumor macrolide polymer and a preparation method and application thereof

The present application relates to the field of polymer chemistry and biomedical technology, and particularly relates to a macrocyclic lactone polymer shown in formula (I) which is used for preventing or treating hyperproliferative diseases, including liver cancer, leukemia, breast cancer, colon adenocarcinoma, gastric cancer, lung cancer, Barrett's esophageal cancer, cervical cancer, pancreatic cancer, endometrial cancer, bone cancer, lymphoma, kidney cancer, brain cancer, nerve cancer, nasopharyngeal cancer, oral cancer, bladder cancer, colorectal cancer and melanoma, and has the potential to be developed into a new type of antitumor drug.
Owner:OCEAN UNIV OF CHINA

Isoxazoline and macrocyclic lactone microspheres

The invention describes an extended-release composition comprising PLGA or PLA polymeric microspheres comprising an isoxazoline, preferably sarolaner, and a macrocyclic lactone, preferably moxidectin, and wherein the composition further comprises at least one pharmaceutically acceptable excipient; and uses thereof.
Owner:ZOETIS SERVICES LLC

Pyrazine macrolide compound and use thereof

The present invention relates to a pyrazine macrolide compound and the use thereof. Specifically disclosed is a compound as represented by formula I or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits activity against bacteria, mycoplasmas, or chlamydias, and is useful for preventing and / or treating diseases caused by bacteria, mycoplasmas, or chlamydias. Further, the compound of the present application can achieve an antibacterial activity comparable to or better than that of azithromycin or solithromycin at a lower dosage. Furthermore, the compound of the present application achieves a superior antibacterial effect on Gram-positive bacteria. Still furthermore, the compound of the present application exhibits a better inhibitory activity against mycoplasmas and a lower hepatotoxicity.
Owner:EVOPOINT BIOSCIENCES CO LTD

Novel 16-membered macrolide compound as well as preparation method and application thereof in prevention and control of agricultural and forestry pests

The invention relates to a novel 16-membered macrolide compound 13alpha-O-alpha-L-oleandrosyl-23-alpha-hydroxy-25-isopropyl milbemycin beta3, a preparation method of the novel 16-membered macrolide compound 13alpha-O-alpha-L-oleandrosyl-23-alpha-hydroxy-25-isopropyl milbemycin beta3, and an application of the novel 16-membered macrolide compound 13alpha-O-alpha-L-oleandrosyl-23-alpha-hydroxy-25-isopropyl milbemycin
Owner:TAIZHOU VOCATIONAL COLLEGE OF SCI & TECH

Macrolide brefeldin a ester derivatives and use thereof

The ester derivatives of brefeldin A represented by Formula (I) in the inhibition of tumor proliferation. The compounds are prominent in the prevention or treatment of hyperproliferative diseases, including liver cancer, leukemia, breast cancer, colon adenocarcinoma, gastric cancer, lung cancer, Bart's esophageal cancer, cervical cancer, pancreatic cancer, endometrial cancer, bone cancer, lymphoma, kidney cancer, brain cancer, nerve cancer, nasopharyngeal cancer, oral cancer and colorectal cancer, and have the potential to be developed as antitumor agents.
Owner:OCEAN UNIV OF CHINA

Method for preparing ester compound and macrolide compound

The invention discloses a method for preparing an ester compound and a macrolide compound, and belongs to the technical field of organic chemistry, the preparation method of the ester compound is as follows: in an organic solvent, an alpha-carbonyl alkenyl ester compound reacts with alcohol or phenol under the catalytic condition of alkali to obtain the ester compound; the preparation method of the macrolide compound comprises the following step: in an organic solvent, carrying out intramolecular hydroxyl reaction on an alpha-carbonyl alkenyl ester compound under the catalysis condition of alkali or acid, thereby obtaining the macrolide compound. The method is wide in substrate range, high in practicability and high in yield, racemization of a carboxylic acid alpha-chiral center can be inhibited in intermolecular esterification reaction and macrocyclic lactonization reaction, and the method can be applied to total synthesis of a Brevicidine natural product containing a 13-membered cyclic ester peptide core structure; the method disclosed by the invention has the advantages of mild reaction conditions, simplicity, easiness in operation, wide substrate adaptability, no racemization of the product and the like.
Owner:GUANGZHOU MEDICAL UNIV

Method for producing macrolide compound

Disclosed are a method for producing pladienolide D that includes a step that reacts a compound represented by formula (A1) with a compound represented by formula (B1) in the presence of a metal catalyst to obtain a compound represented by formula (C1) (in the formulas, X means hydrogen, optionally substituted boryl, optionally substituted stannyl, or optionally substituted silyl, R4 is hydrogen, etc., R5 is optionally substituted benzoyl, etc., and R1 and R2 each independently are hydrogen, etc.) and crystals of a solvate of pladienolide D.
Owner:EISAI R&D MANAGEMENT CO LTD

Anti-parasitic compositions of macrolides

PendingCN121941412ABiocideAnimal repellantsAntiparasiticAvermectin
The present invention provides an anti-parasitic composition for use in the treatment or prevention of a parasitic infection in a mammal, the anti-parasitic composition comprising a macrolide, in particular a combination of ivermectin, abamectin and doramectin. The invention also provides a method of treating a parasitic infection in a mammal by administering to the mammal an effective amount of an anti-parasitic composition comprising ivermectin, abamectin, and doramectin, and a method of preparing the anti-parasitic composition.
Owner:ELANCO SAUDE ANIMAL LTDA

Recombinant macrolide enzyme as well as preparation method and application thereof

According to the scheme, the recombinant macrolide enzyme and the preparation method and application thereof are provided, the amino acid sequence of the recombinant macrolide enzyme is shown as SEQ ID NO.1, and the recombinant macrolide enzyme is obtained by site-directed mutagenesis of an erythromycin esterase family protein sequence derived from enterobacter hormaechei; the mutation sites are as follows: the 44 glutamic acid is mutated into asparagine, the 55 tyrosine is mutated into proline, the 153 proline is mutated into alanine, and the 219 serine is mutated into glutamic acid, so that the specific macrolide lactonase which is efficient, stable, easy to prepare on a large scale and more suitable for environmental requirements is prepared, and macrolide antibiotic pollution is removed; and the method has good economic benefits and practical values.
Owner:浙江泰林生命科学有限公司

Novel Fe-C-N-coated Au material and preparation method and application thereof

The invention discloses a novel Fe-C-N-coated Au material and a preparation method and application thereof.According to the Fe-C-N-coated Au material, iron monatomic nano-enzyme Fe-C-N serves as a core, gold nanoparticles are loaded on the surface, the Fe-C-N nanoparticles and a HAuCl4 aqueous solution are stirred at low temperature, then an ice-cold NaBH4 solution is slowly added into a mixed solution, and the Fe-C-N-coated Au material is obtained after reaction and treatment. The novel Fe-C-N-coated Au material disclosed by the invention can be used for rapidly and sensitively detecting the azithromycin or macrolide drug-resistant gene ermB.
Owner:CENT SOUTH UNIV

Ti3C2Tx hollow microsphere as well as preparation method and application thereof

The invention relates to the technical field of adsorption material preparation, in particular to Ti3C2Tx hollow microspheres and a preparation method and application thereof.The preparation method of the Ti3C2Tx hollow microspheres comprises the steps that S1, LiF is added into an HCl solution, first stirring is conducted till LiF is dissolved, Ti3AlC2 is added, etching, first centrifugation, washing, ultrasonic treatment and second centrifugation are conducted, and single-layer Ti3C2Tx dispersion liquid is obtained; s2, the single-layer Ti < 3 > C < 2 > T < x > dispersion liquid obtained in the step S1 and PS pellets are subjected to second stirring, filtering, drying and calcination, and Ti < 3 > C < 2 > T < x > hollow microspheres are obtained; wherein in S2, the mass ratio of the Ti < 3 > C < 2 > T < x > to the PS pellets is 1: (3-7); wherein in the step S2, the second stirring condition is as follows: the second stirring temperature is 20-30 DEG C, and the second stirring time is 12-48 hours. The Ti3C2Tx hollow microspheres provided by the invention have relatively fast adsorption kinetics and relatively large adsorption capacity for removing tetracycline and macrolide antibiotics, and are high in physical and chemical stability and strong in pollution resistance.
Owner:GANSU AGRI UNIV

Injectable antibiotic formulations and use thereof

Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
Owner:DECHRA VETERINARY PRODUCTS LLC